electroCore Granted Three New U.S. Patents ROCKAWAY, N.J. , April 12, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received patent issue notifications from the United States Patent and
Record revenue of approximately $2.8M expected for the three months ended March 31, 2023 ; 46% increase over first quarter of 2022 Revenue in first full quarter of Truvaga sales of approximately $147,000 expected ROCKAWAY, N.J. , April 17, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc.
ROCKAWAY, N.J. , April 19, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that it will report financial results for the first quarter ended March 31, 2023 , after the close of the market on Wednesday, May 3, 2023 .
Clinical trial (n=36) shows the ability of gammaCore (nVNS) to significantly improve the recall of a foreign language compared to sham while simultaneously showing improved focus and decreased fatigue in study participants ROCKAWAY, N.J. , April 24, 2023 (GLOBE NEWSWIRE) -- electroCore,
ROCKAWAY, N.J. , April 26, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), has awarded Emory University and
ROCKAWAY, N.J. , May 01, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR) a commercial-stage bioelectronic medicine and wellness company, today announced that electroCore’s Chief Executive Officer, Dan Goldberger , will present at the Annual Aegis Virtual Conference being
Record first quarter 2023 net sales of $2.8 million , approximately 46% over first quarter 2022 Company to host a conference call and webcast today, May 3, 2023 , at 4:30 PM EDT ROCKAWAY, N.J. , May 03, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic
ROCKAWAY, N.J. , May 23, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR) a commercial-stage bioelectronic medicine and wellness company, today announced that electroCore’s Chief Executive Officer, Dan Goldberger , will present at the 13th Annual LD Micro Invitational XIII
ROCKAWAY, N.J. , May 26, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the resignation of its Founder and former CEO, JP Errico from the Board of Directors. Mr.
ROCKAWAY, N.J. , June 13, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that “SUNCT/ SUNA with neurovascular conflict: consider nVNS,” will be presented at the American Headache Society’s 65 th Annual